警惕紫杉醇脂质体所致Ⅳ度骨髓抑制

Pay Attention to Ⅳ Degree of Marrow Depression induced by Paclitaxel liposome

临床药师全程参与1例Ⅳ度骨髓抑制患者的救治过程,结合紫杉醇相关不良反应基因多态性检测,分析骨髓抑制与药物之间的关系,并对治疗方案提出修改建议,保障了患者的用药安全和疗效。

Clinical pharmacists have involved in the treatment of the patient with IV degree of marrow depression,analyzing the relationship between marrow depression and drugs,combined with the polymorphisms of the related genes that impact the paclitaxel toxicity,proposing the suggestion of adjusting drug therapy to ensure the safe and effective clinical treatment for the patient.